Načítá se...
Expectations and Challenges of First-Line Maintenance Therapy for Advanced Ovarian Cancer
The incidence of ovarian cancer, which has had a poor prognosis, is increasing annually. Currently, the prognosis is expected to improve with the use of molecular-targeted drugs and immune checkpoint inhibitors as maintenance therapies after the first-line chemotherapy. The GOG218 and ICON7 studies...
Uloženo v:
| Vydáno v: | Medicina (Kaunas) |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
MDPI
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8155998/ https://ncbi.nlm.nih.gov/pubmed/34063455 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/medicina57050501 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|